On the other hand, I suppose there is some strategic value to a prospective acquirer where shareholders could realize an attractive return. That is, it’s conceivable to me that their product is ...

H.C. Wainwright analyst Douglas Tsao views the agreement of joint stipulation between Arcutis Biotherapeutics (ARQT) and Padagis to the ongoing ...